- Home
- LEGN vs CAI Comparison
LEGN vs CAI Comparison
Compare LEGN & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEGN | CAI |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.2B |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | LEGN | CAI |
|---|---|---|
| Price | $17.73 | $28.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $61.33 | $30.91 |
| AVG Volume (30 Days) | 1.6M | ★ 4.4M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 69.79 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $812,033,000.00 |
| Revenue This Year | $42.68 | $25.24 |
| Revenue Next Year | $30.52 | $22.32 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 96.97 |
| 52 Week Low | $16.24 | $14.19 |
| 52 Week High | $37.50 | $34.54 |
Technical Indicators
Market Signals| Indicator | LEGN | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 35.03 | 64.42 |
| Support Level | $17.81 | $25.11 |
| Resistance Level | $19.36 | $28.88 |
| Average True Range (ATR) | 0.85 | 1.30 |
| MACD | -0.17 | -0.32 |
| Stochastic Oscillator | 8.33 | 55.66 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.